University of Birmingham Enterprise welcomes progress in new treatment for Idiopathic Intracranial Hypertension (IIH)
University of Birmingham Enterprise welcomes the floatation of Invex Therapeutics, which is developing an innovative new treatment approach for IIH discovered at the University of Birmingham, UK. Invex Therapeutics Ltd (Invex, ASX: IXC, or the Company)...Research from University of Birmingham shows new antimicrobial coating could be key to fighting hospital acquired infections
New Antimicrobial Coating Could be Key in Fight Against Hospital-Acquired Infections Scientists at the University of Birmingham have created an antimicrobial coating for steel surfaces which has proven to rapidly kill bacteria that cause some of the most common...University of Birmingham experts could help NASA’s Mission to Mars
NASA scientists and astronauts will visit the University of Birmingham to discuss how drug discoveries in NHS patients could reduce brain pressure during space travel to allow them to go beyond the Moon. One of NASA’s missions is to see the first humans set foot on...New collaboration between Aston Business School, University of Birmingham and Minerva Business Angels launches
Warm welcome for Minerva Birmingham – new collaboration between Aston Business School, University of Birmingham and Minerva Business Angels launches 17 April 2019: West Midlands business leaders, entrepreneurs and investors have welcomed the launch of a...University of Birmingham researchers one step closer to developing eye drops for age-related macular degeneration
Scientists at the University of Birmingham, UK, are one step closer to developing an eye drop that could revolutionise treatment for age-related macular degeneration (AMD). AMD is the leading cause of blindness in the developed world. Its prevalence is...
